The Best Bladder cancer treatment plans in Baltimore, Maryland

John Gearhart, MD is a renowned institution located at 601 North Caroline Street in Baltimore, Maryland, United States. Specializing in pediatric urology and urologic surgery, Dr. John P. Gearhart is a professor at the Johns Hopkins School of Medicine. With a focus on evaluating and treating children with major congenital birth defects, bladder exstrophy, disorders of sexual development, and childhood urinary cancers, Dr. Gearhart is a pioneer in the field. Due to recent traffic delays caused by the collapse of the Francis Scott Key Bridge, patients are advised to plan ahead when traveling to appointments. Additionally, masks are strongly recommended but not required at Johns Hopkins Medicine clinical locations in Maryland, in accordance with the state's guidelines.

Jean Hoffman-Censits, MD is a leading genitourinary cancer specialist located at 1650 Orleans Street in Baltimore, Maryland. Dr. Hoffman-Censits is a co-leader of the Women’s Bladder Cancer Program at the Greenberg Bladder Cancer Institute at Johns Hopkins University School of Medicine. She specializes in treating patients with urothelial cancers of the bladder and upper tract. Dr. Hoffman-Censits is dedicated to conducting research on urothelial cancers and has been involved in groundbreaking clinical trials that have led to new treatments for bladder and upper tract urothelial cancers. She is a member of several prestigious medical associations and has published numerous research articles in top medical journals. Patients visiting Dr. Jean Hoffman-Censits can expect compassionate and expert care for their genitourinary cancer needs. The institution strongly recommends masks for all patients, although they are not required. Due to recent bridge collapse in the area, patients are advised to anticipate travel delays when coming for appointments. Dr. Hoffman-Censits and her team are committed to providing the highest quality of care to all their patients, and strive to make each patient's experience as comfortable and effective as possible.

Max Kates, M.D. is a leading institution located in Timonium, Maryland, United States, specializing in urologic oncology. Dr. Max Kates, an Associate Professor of Urology and Oncology, heads the Division of Urologic Oncology at the prestigious Brady Urological Institute. With expertise in bladder and prostate cancer, Dr. Kates offers personalized treatment plans utilizing open, endoscopic, and robotic surgical approaches. He is dedicated to open communication with patients, their families, and referring providers to ensure a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic at Johns Hopkins Greenberg Bladder Cancer Institute, Dr. Kates collaborates with a team to deliver cutting-edge precision medicine approaches for bladder cancer patients. His research interests focus on novel treatments for urinary tract cancers, with over 135 journal articles to his credit. Dr. Kates is also the principal investigator on multiple trials, including the groundbreaking EA8212 BRIDGE trial comparing BCG to GemDoce chemotherapy for early stage bladder cancer.